The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Coronary Care Units

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Coronary Care Units


High impact information on Coronary Care Units

  • Despite the fact that all our assumptions were slanted to favor the current standard policy of admission to a coronary-care unit, our analysis shows that admission to an intermediate-care unit providing resuscitative facilities and prophylactic lidocaine is highly cost effective [6].
  • Studies of the health effects of several major interventions in relation to their costs--Pap smears, mammography, coronary care units, bypass surgery, and cholesterol reduction--indicate the kinds of choices to be made [7].
  • The interval between the initial electrocardiogram and initiation of treatment with TPA was less when the drug was first administered in the emergency department (46.8 +/- 23.4 minutes) rather than after transfer to the coronary care unit (82.1 +/- 34.7 minutes) [8].
  • Bedside measurement of creatine kinase to guide thrombolysis on the coronary care unit [9].
  • Eighty-eight patients admitted to a coronary care unit with chest pain of varying etiology but without ECG evidence of an acute transmural myocardial infarction had myocardial scintigrams using technetium-99m stannour pyrophosphate (99m-Tc-PYP) [10].

Chemical compound and disease context of Coronary Care Units


Biological context of Coronary Care Units


Anatomical context of Coronary Care Units


Associations of Coronary Care Units with chemical compounds


Gene context of Coronary Care Units


Analytical, diagnostic and therapeutic context of Coronary Care Units


  1. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Norhammar, A., Tenerz, A., Nilsson, G., Hamsten, A., Efendíc, S., Rydén, L., Malmberg, K. Lancet (2002) [Pubmed]
  2. Use of atropine in patients with acute myocardial infarction and sinus bradycardia. Scheinman, M.M., Thorburn, D., Abbott, J.A. Circulation (1975) [Pubmed]
  3. A randomized study comparing propranolol and diltiazem in the treatment of unstable angina. Théroux, P., Taeymans, Y., Morissette, D., Bosch, X., Pelletier, G.B., Waters, D.D. J. Am. Coll. Cardiol. (1985) [Pubmed]
  4. Cortisol and vital exhaustion in relation to significant coronary artery stenosis in middle-aged women with acute coronary syndrome. Koertge, J., Al-Khalili, F., Ahnve, S., Janszky, I., Svane, B., Schenck-Gustafsson, K. Psychoneuroendocrinology (2002) [Pubmed]
  5. Ulceration and stricture of the esophagus due to oral potassium chloride (slow release tablet) therapy. Lambert, J.R., Newman, A. Am. J. Gastroenterol. (1980) [Pubmed]
  6. Care of patients with a low probability of acute myocardial infarction. Cost effectiveness of alternatives to coronary-care-unit admission. Fineberg, H.V., Scadden, D., Goldman, L. N. Engl. J. Med. (1984) [Pubmed]
  7. Some of the tough decisions required by a national health plan. Russell, L.B. Science (1989) [Pubmed]
  8. An analysis of time delays preceding thrombolysis for acute myocardial infarction. Sharkey, S.W., Bruneete, D.D., Ruiz, E., Hession, W.T., Wysham, D.G., Goldenberg, I.F., Hodges, M. JAMA (1989) [Pubmed]
  9. Bedside measurement of creatine kinase to guide thrombolysis on the coronary care unit. Downie, A.C., Frost, P.G., Fielden, P., Joshi, D., Dancy, C.M. Lancet (1993) [Pubmed]
  10. Acute subendocardial myocardial infarction in patients. Its detection by Technetium 99-m stannous pyrophosphate myocardial scintigrams. Willerson, J.T., Parkey, R.W., Bonte, F.J., Meyer, S.L., Stokely, E.M. Circulation (1975) [Pubmed]
  11. Insertion/deletion polymorphism in the angiotensin-converting enzyme gene and risk of and prognosis after myocardial infarction. Samani, N.J., O'Toole, L., Martin, D., Rai, H., Fletcher, S., Lodwick, D., Thompson, J.R., Morice, A.H., Channer, K., Woods, K.L. J. Am. Coll. Cardiol. (1996) [Pubmed]
  12. Serum C-reactive protein concentration in acute myocardial infarction and its relationship to mortality during 24 months of follow-up in patients under thrombolytic treatment. Pietilä, K.O., Harmoinen, A.P., Jokiniitty, J., Pasternack, A.I. Eur. Heart J. (1996) [Pubmed]
  13. Complexity of enzyme release during acute myocardial infarction in a controlled study with early nifedipine treatment. Loogna, E., Sylvén, C., Groth, T., Mogensen, L. Eur. Heart J. (1985) [Pubmed]
  14. On the interpretation of serial laboratory measurements in acute myocardial infarction. Albert, A., Harris, E.K., Chapelle, J.P., Heusghem, C., Kulbertus, H.E. Clin. Chem. (1984) [Pubmed]
  15. Development and clinical evaluation of a microcentrifugal analyzer method for determining creatine kinase MB isoenzyme. Massey, T.H., Butts, W.C. Clin. Chem. (1983) [Pubmed]
  16. Decreased nocturnal melatonin levels during acute myocardial infarction. Domínguez-Rodríguez, A., Abreu-González, P., García, M.J., Sanchez, J., Marrero, F., de Armas-Trujillo, D. J. Pineal Res. (2002) [Pubmed]
  17. Effect of intravenous isosorbide dinitrate versus nitroglycerin on elevated pulmonary arterial wedge pressure during acute myocardial infarction. Cintron, G.B., Glasser, S.P., Weston, B.A., Linares, E., Conti, C.R. Am. J. Cardiol. (1988) [Pubmed]
  18. Heparin-induced thrombocytopenia: a prospective study. Johnson, R.A., Lazarus, K.H., Henry, D.H. Am. J. Hematol. (1984) [Pubmed]
  19. Circulating neuropeptide Y in humans: relation to changes in catecholamine levels and changes in hemodynamics. Hauser, G.J., Danchak, M.R., Colvin, M.P., Hopkins, R.A., Wocial, B., Myers, A.K., Zukowska-Grojec, Z. Neuropeptides (1996) [Pubmed]
  20. Atropine dose in acute myocardial infarction in man. Klein, M.D., Barret, J., Ryan, T.J., Flessas, A.P. Cardiology (1975) [Pubmed]
  21. Reduced neutrophil superoxide anion release after prolonged infusions of lidocaine. Peck, S.L., Johnston, R.B., Horwitz, L.D. J. Pharmacol. Exp. Ther. (1985) [Pubmed]
  22. Myocardial rupture after acute myocardial infarction. Ten year review. Feneley, M.P., Chang, V.P., O'Rourke, M.F. British heart journal. (1983) [Pubmed]
  23. "Stress" hyperglycaemia during acute myocardial infarction: an indicator of pre-existing diabetes? Husband, D.J., Alberti, K.G., Julian, D.G. Lancet (1983) [Pubmed]
  24. Short-term efficacy of oral verapamil in rest angina. A double-blind placebo controlled trial in CCU patients. Mehta, J., Pepine, C.J., Day, M., Guerrero, J.R., Conti, C.R. Am. J. Med. (1981) [Pubmed]
  25. Raised plasma urea levels after myocardial infarction. Moseley, M.J., Sawminathan, R., Morgan, B. Arch. Intern. Med. (1981) [Pubmed]
  26. The short-term effect of intravenous nitroglycerin on haematocrit; an additional benefit in patients with myocardial ischaemia? Arend, S.M., Bax, J.J., Hermans, J., van der Wall, E.E., Sedney, M.I. Eur. Heart J. (1994) [Pubmed]
  27. Proton-pump inhibitor therapy for acetylsalicylic acid associated upper gastrointestinal symptoms: a randomized placebo-controlled trial. Laheij, R.J., Van Rossum, L.G., Jansen, J.B., Verheugt, F.W. Aliment. Pharmacol. Ther. (2003) [Pubmed]
  28. Serum levels of osteoprotegerin and RANKL in patients with ST elevation acute myocardial infarction. Crisafulli, A., Micari, A., Altavilla, D., Saporito, F., Sardella, A., Passaniti, M., Raffa, S., D'anneo, G., Lucà, F., Mioni, C., Arrigo, F., Squadrito, F. Clin. Sci. (2005) [Pubmed]
  29. Markers of activated coagulation for early diagnosis of acute myocardial infarction. Mair, J., Genser, N., Maier, J., Lechleitner, P., Dienstl, F., Puschendorf, B. Clin. Chim. Acta (1997) [Pubmed]
  30. Comparative short-term prognostic value of hemostatic and inflammatory markers in patients with non-ST elevation acute coronary syndromes. Passoni, F., Morelli, B., Seveso, G., Lazzati, L., Beria, G., Del Rosso, G., D'Urbano, M., Cafiero, F., Mariani, G., De Servi, S. Italian heart journal : official journal of the Italian Federation of Cardiology. (2002) [Pubmed]
  31. Prognostic value of plasma neuropeptide-Y in coronary care unit patients with and without acute myocardial infarction. Ullman, B., Hulting, J., Lundberg, J.M. Eur. Heart J. (1994) [Pubmed]
  32. Serum myoglobin determination: laboratory and clinical evaluation. Sonnemaker, R.E., Daniels, D.L., Craig, W.E., Floyd, J.L., Bode, R.F. J. Nucl. Med. (1979) [Pubmed]
  33. Intravenous diltiazem in the treatment of unstable angina: a study of efficacy and tolerance. Colombo, G., Zucchella, G., Planca, E., Grieco, A., Vescovini, R. Clinical therapeutics. (1987) [Pubmed]
  34. Clinical assessment of serum myosin light chains in the diagnosis of acute myocardial infarction. Trahern, C.A., Gere, J.B., Krauth, G.H., Bigham, D.A. Am. J. Cardiol. (1978) [Pubmed]
  35. Use of tissue plasminogen activator in the coronary care unit for acute closure after coronary angioplasty. Alzarka, A., Haft, J.I., Goldstein, J.E. Chest (1990) [Pubmed]
  36. A noninvasive assessment of pulmonary perfusion abnormality in patients with primary pulmonary hypertension. Ting, H., Sun, X.G., Chuang, M.L., Lewis, D.A., Hansen, J.E., Wasserman, K. Chest (2001) [Pubmed]
WikiGenes - Universities